Alert detail
FDA Approval: SARCLISA ESCENA (ISATUXIMAB-IRFC) — Type 3 - New Dosage Form
What changed
New subcut isatuximab form needs its own J-code; don't reuse J9354.
Who’s affected: Hematology billing teams · Effective: July 9, 2026
Primary source: View the official CMS/MAC document ↗
Get the action steps and full analysis
The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.